23.5 C
New York
Thursday, July 3, 2025

Tag: meeting

Record date for reverse share split in Fingerprint Cards AB (publ)

At the Annual General Meeting of Fingerprint Cards AB (publ) (“FPC” or the “Company”) held on June 24, 2025, a resolution was passed to carry out a reverse share split, whereby two thousand (2,000) existing shares will be consolidated into one (1) new share (reverse split 1:2,000). The AGM also resolved to authorize the Board of Directors to determine the record date for the reverse split.

Bond, debond, recycle – tesa opens new Debonding on Demand laboratory in Singapore

Reliable in use, removable when needed – Next-gen adhesive solutions that can be precisely and residue-free removedInnovation hub with impact – Accelerating customer-specific developments...

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

BEIJING, SHANGHAI and BOSTON, July 2, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND)...

Dizal’s ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20insApproval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which...

First AML expands Tranche 2 leadership in Australia following major client wins across law and real estate

SYDNEY, July 3, 2025 /PRNewswire/ -- First AML, the leading end-to-end anti-money laundering (AML) compliance platform continues its rapid growth in Australia as Tranche...

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

The fifth edition of this prestigious list welcomes 14 new entries representing 23 destinations across Asia  LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight...

ASIA’S 50 BEST BARS 2025 REVEALS THE ESTABLISHMENTS RANKED ON THE EXTENDED 51-100 LIST

The fifth edition of this prestigious list welcomes 14 new entries representing 23 destinations across Asia  LONDON, July 3, 2025 /PRNewswire/ -- Casting a spotlight...

GR Silver Mining Announces Incentive Plan Grants

VANCOUVER, BC, July 2, 2025 /CNW/ - GR Silver Mining Ltd. ("GR Silver Mining" or the "Company") (TSXV: GRSL) (OTCQB: GRSLF) (FRANKFURT: GPE) – announces...

Centrus Energy to Participate in Upcoming Investor Events

BETHESDA, Md., July 2, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today announced that management will participate in the following upcoming conferences. ...

Borr Drilling Limited plans to strengthen the balance sheet for continued growth and announces CEO succession plan

Highlights Borr financing package to increase liquidity by $200 million, strengthening balance sheet for continued growthBruno Morand to become CEO effective September 1, 2025, following...

INOVIO Announces Proposed Public Offering

PLYMOUTH MEETING, Pa., July 2, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to...

Vital Farms Appoints Billy Cyr to Board of Directors

AUSTIN, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced the appointment of William B. (Billy) Cyr to its board of directors effective July 1, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMeeting